These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 8873514)

  • 1. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.
    Sarasin FP; Giostra E; Hadengue A
    Am J Med; 1996 Oct; 101(4):422-34. PubMed ID: 8873514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
    Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
    Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
    Lin OS; Keeffe EB; Sanders GD; Owens DK
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L; Gaiani S; Casali A; Serra C; Piscaglia F
    Radiol Med; 1997; 94(1-2):4-7. PubMed ID: 9424649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective.
    Sarasin FP; Giostra E; Mentha G; Hadengue A
    Hepatology; 1998 Aug; 28(2):436-42. PubMed ID: 9696009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening.
    Kuo MJ; Chen HH; Chen CL; Fann JC; Chen SL; Chiu SY; Lin YM; Liao CS; Chang HC; Lin YS; Yen AM
    World J Gastroenterol; 2016 Mar; 22(12):3460-70. PubMed ID: 27022228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
    Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
    Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
    Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the single liver nodule in a cirrhotic patient: a decision analysis model.
    El-Serag HB; Mallat DB; Rabeneck L
    J Clin Gastroenterol; 2005 Feb; 39(2):152-9. PubMed ID: 15681913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
    Ruelas-Villavicencio AL; Vargas-Vorácková F
    Ann Hepatol; 2004; 3(4):152-9. PubMed ID: 15657557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
    Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
    Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hepatocellular carcinoma.
    De Masi S; Tosti ME; Mele A
    Dig Liver Dis; 2005 Apr; 37(4):260-8. PubMed ID: 15788210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
    Ladabaum U; Cheng SL; Yao FY; Roberts JP
    Clin Transplant; 2011; 25(2):283-91. PubMed ID: 20156221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance for hepatocellular carcinoma: does it work?].
    Kchaou-Ouakaa A; Belhadjbrik N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2007 Oct; 85(10):866-70. PubMed ID: 18236810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Parikh ND; Singal AG; Hutton DW; Tapper EB
    Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for hepatocellular carcinoma.
    Nguyen MH; Keeffe EB
    J Clin Gastroenterol; 2002; 35(5 Suppl 2):S86-91. PubMed ID: 12394211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers.
    Kang JY; Lee TP; Yap I; Lun KC
    J Gastroenterol Hepatol; 1992; 7(5):463-8. PubMed ID: 1382657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.